Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 23.56 | 22.11 | 7 |
| OPM % | 23.47 | 19.13 | - |
| PBDT | 5.17 | 3.94 | 31 |
| PBT | 5.01 | 3.75 | 34 |
| NP | 5.05 | 3.68 | 37 |
